SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-044169
Filing Date
2023-02-22
Accepted
2023-02-22 08:03:17
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d465041d424b5.htm 424B5 487519
2 GRAPHIC g465041g88f87.jpg GRAPHIC 30115
3 GRAPHIC g465041g88f88.jpg GRAPHIC 32531
4 GRAPHIC g469432g45q45.jpg GRAPHIC 31177
  Complete submission text file 0001193125-23-044169.txt   606733
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-269899 | Film No.: 23650579
SIC: 2834 Pharmaceutical Preparations